Flatiron Health’s Post

A new report, recently published by an ISPOR Task Force including Flatiron’s Blythe Adamson, PhD, MPH and other industry experts, provides actionable takeaways for HTA agencies and policymakers supporting and potentially standardizing the use of EHR-derived #RWD for #HTAs. Introducing a framework and accompanying ISPOR SUITABILITY Checklist, this ISPOR Good Practices Report addresses the validity and relevance of EHR-derived #RWD to fill evidence gaps and improve decision-making. Visit our website for the full report and to learn more about why this matters ⬇️ http://spkl.io/604047y5i

RECENTLY ANNOUNCED: Flatiron Health’s newly launched Trusted Partners Network is a curated selection of technology and service providers with proven positive impact in oncology. This initiative helps partners expand their reach and drives greater value for community oncology. Read more from Flatiron's VP, Strategic Partnerships and Alliances, Nina Chavez https://lnkd.in/eY_63UiW

Hear from the authors of the American Society of Clinical Oncology (ASCO) JCO publication “Utility of automated data transfer for cancer clinical trials” as they review their research findings on EHR-to-EDC technology in #clinicaltrials and how it can reduce data management burden and enhance overall efficiency. 📆 Join us on July 17th at 11 am to walk away with: - Tangible examples of how EHR-to-EDC technology is increasing the efficiency of trial data acquisition and management and lowering the burden to site staff - Suggested change management strategies for successful implementation https://lnkd.in/etmGFYAR

#Clinicaltrials are often burdensome and inefficient for practices. But the right technology can more seamlessly integrate research into everyday clinical care. Hear Kathy Oubre, CEO of Pontchartrain Cancer Center (PCC), share how Flatiron’s OncoEMR & OncoTrials streamline their research operations across 21 trials, serving over 120 patients. Watch now to learn more about these solutions, and why PCC said they take their research program “to another level.” http://spkl.io/60474A4A3

#AI offers the ability to rapidly scale our understanding of patient experiences. Flatiron's Chief of AI and VP of Data Science, Will Shapiro, sat down with Patti Peeples, PhD to share his perspective ⬇ "New therapies are introduced regularly, new biomarkers become relevant to the standard of care, and new variables, such as social determinants of health, become crucial for the analyses researchers want to perform. The ability to dynamically update what we learn from each patient is critically important.” Read more on The Evidence Base® http://spkl.io/60484A4NI

“The way we learn what works and to make recommendations to our patients is based on #clinicaltrials. It’s really a crisis. And it’s a societal imperative, in my opinion, to fix this problem of clinical trial representativeness.” Building off an article published in NEJM Evidence, data-driven approaches have the ability to transform #oncology trials, improve patient outcomes, and address disparities in health care. Read more in a recent interview with Neal Meropol, Head of Clinical Oncology at Flatiron Health, and The Evidence Base®. http://spkl.io/604247EtE

After another incredible #ASCO24, Neal Meropol shared his thoughts on themes that emerged, their relevance to Flatiron Health, and their impact on the future of cancer care. Click below to read more ⬇️ http://spkl.io/60474A4FD

Scientific advancements have occurred across almost every realm of #breastcancer in the last three decades, including the discovery of novel biomarkers, the development and approval of novel therapies, and our understanding of the disease. Join a panel of experts from across the industry, including #clinicalresearch, drug commercialization, and clinical practice, for the current state of breast cancer research today and where it’s headed ⬇️ ⭐Bridging Innovation and Practice: The Current and Future Landscape of Breast Cancer Care 🗣️Neelima Denduluri MD, FASCO, AstraZeneca; Angela DeMichele MD, MSCE, FASCO, University of Pennsylvania School of Medicine; iuliana shapira, Regional Cancer Care Associates; and moderated by Emily Castellanos , Flatiron Health 📅Tuesday, July 23rd 12-1 PM ET Secure your spot & ask our panel of experts your questions directly. Register & submit questions now: http://spkl.io/60414ALB5

Flatiron Health’s VP Strategic Partnerships and Alliances, Nina Chavez, shares how our newly launched Trusted Partner Network helps partners expand their reach and drive greater value for community oncology. Read more to learn about how we continue to innovate and help our customers access the solutions they need to thrive. https://lnkd.in/eY_63UiW